Alison Hopkins

Chief Executive: Accelerate CIC

Alison Hopkins is Chief Executive of Accelerate Community Interest Company. She led the spin out of the specialist wound and lymphoedema service from the NHS in 2011 to develop what has become a leading edge company in the social enterprise world.  Accelerate not only provides service across Tower Hamlets, via a multidisciplinary team but also provides complex management for patients from across London and the South East.

Alison has been in the tissue viability nursing specialism since 1989 and has led the growth of Accelerate in both in turnover and personnel demonstrating the visible worth of clinical leadership in the context of business development.

She has an MSc in Psychology and Health and started her life in the health world as a District Nurse. Her passion remains the creative use of compression therapy within leg ulcer management and quality of life issues for all patients. She continues to successfully raise the profile of complex wounds and lymphoedema within the long term conditions agenda. Alison held the position of Chair and Trustee for the Tissue Viability Society (2010-14).  She has a number of publications, is a national and international speaker and was proud to launch the opening of the Accelerate Treatment Centre as the first Centre of Excellence for complex wound and lymphoedema care in September 2015.

Dr Patel has advised many NHS Trusts on infection prevention control and patient safety matters including the management of healthcare associated infections and antimicrobial resistance incidents.


During the CDI epidemic he advised many NHS Trusts and strategic health authorities on the management and control of CDI outbreaks and participated in over 30 peer review visits to provide advice and support.


He has served on several health regulator review panels: Regulation and Quality Improvement Authority (RQIA), Northern Ireland and Healthcare Inspectorate for Wales (HIW), investigating outbreaks of Clostridium difficile infections (CDI)in acute hospitals and Health Information & Quality Authority, Ireland maternal death inquiry and more recently a neonatal deaths inquiry for HIW.


As consultant clinical adviser for National Institute for Health and Clinical Excellence (NICE) he was co-organiser for Prevention and control of healthcare-associated infections (PH36), producing  quality improvement statements which provide clear markers of excellence in infection prevention and control at a management or organisational level and more recently as a Specialist committee member helped produce NICE quality standards [QS113] for Healthcare associated infections.

Dr Bharat Patel

Consultant Medical Microbiologist, Public Health Laboratory, London, Public Health England

Dr Cliodna McNulty

Head of Primary Care Unit – Public Health England (Health Protection Agency)

                                    Consultant Medical Microbiologist and Honorary Visiting Professor for Cardiff University

Professor Cliodna McNulty is a clinical microbiologist, and leads the Gloucester Public Health England Primary Care Unit.  The Unit aims to improve the management of infections in the community through research, guidance development and education of the Public and young people through GP staff and schools.  She leads the English national antibiotic guidance and diagnostic guides for primary care, and the national English TARGET antibiotics website educational resources for general practitioners. She has led numerous large surveys on the public’s use of and attitudes to antibiotics and resistance.  Professor McNulty is an expert advisor to the ECDC Technical Advisory Committees for European Antibiotic Awareness Day. Cliodna leads the e-bug project which provides fun resources and games for young people covering microbes, prevention of infection and antibiotics.

Mark Webb

Mark Webb, 48, works a four-day week as Head of Group Social Media for Dixons Carphone plc, where he has been for some eleven years. Prior to that he held various pr and communications roles at David Lloyd Leisure, The Walt Disney Company and Disneyland Paris.

Mark has Multiple Sclerosis, officially ‘Relapsing Remitting’, but potentially ‘Secondary Progressive‘ by now. He ‘celebrates’ his ten-year diagnosis anniversary this May, though he can trace back his first symptoms – intense pins and needles and bladder issues – to 25 years ago. He has twice been hospitalised by UTI’s.

Mark is married with two children, and lives in Bedfordshire. In his spare time he sleeps a lot, but also works hard to raise awareness of disability and specifically Multiple Sclerosis.

Philip Howard

National Project Leads HAI & AMR NHS Improvement

Philip Howard is Consultant Pharmacist in Antimicrobials at the Leeds Teaching Hospitals NHS Trust, AMR Project Lead at NHS-Improvement and Honorary Senior Lecturer at Leeds University.


He is a spokesman for the Royal Pharmaceutical Society on Antimicrobials, and for the charity Antibiotic-Action.


He was a member of the Dept of Health ARHAI Antimicrobial Stewardship Group that produced the original Start Smart then Focus Antimicrobial Stewardship Guidelines, and the HPA Primary Care Unit which helped produce the RCGP TARGET guidance on Antimicrobial Stewardship in Primary Care.


His research interests include Antimicrobial Stewardship, and led the first global hospital Antimicrobial Stewardship survey. He has been involved in AMS education and training across the world.  In 2012, he won the GHP/GSK/UKCPA Clinical Leadership Award.

Dr Ron Daniels

Clinical Advisor (Sepsis) to NHS England, CEO UK Sepsis Trust 

Ron is Chief Executive and one of the founders of the Trust; he developed his passion for improving systems for Sepsis during his Role as a Consultant in Critical Care and Anaesthesia, and his parallel role as CEO of the Global Sepsis Alliance. He is a recognised world expert in sepsis and lectures internationally.


I won’t rest until patients with sepsis are dealt with as quickly and reliably as patients with heart attacks or stroke, every time. I initiated the development of the UK Sepsis Trust when it became clear that to achieve this required not only education, but also engagement.

Dr Susan Hopkins

Consultant in Infectious Diseases & Microbiology, Royal Free London NHS Foundation Trust, Healthcare Epidemiologist, Public Health England, Honorary Senior Lecturer, University College London

Susan is a ‎Healthcare Epidemiologist Consultant in Infectious Diseases and Microbiology at Public Health England. She is Chair of the Overview Committee of the English Surveillance Programme for Antimicrobial Utilisation and Resistance (ESPAUR) which aims to develop, maintain and disseminate robust data relevant to antimicrobial use and stewardship for us across healthcare settings and to measure the impact of antimicrobial use and stewardship on patient safety.

Her main research interests are in outbreak investigation and surveillance and healthcare associated infections. She is a member of many national expert groups and Chairs the Royal College of Physicians working group on HCAI  and sits on the PHE’s AMR Programme Board and on the MHRA Expert Advisory Group on Anti-Infectives. She is Programme Director for the UCL MSc in Healthcare associated Infection Control.

Sara Mumford 

Director of Infection Prevention and Control, Clinical Director of Diagnostics and Pharmacy and Consultant Microbiologist at Maidstone and Tunbridge Wells NHS Trust (MTW)

Sara Mumford is Director of Infection Prevention and Control, Clinical Director of Diagnostics and Pharmacy and Consultant Microbiologist at Maidstone and Tunbridge Wells NHS Trust (MTW).  Sara studied medicine at St Bartholomew’s hospital and did her specialist training at Charing Cross and St George’s Hospitals and Ashford Public Health Laboratory.

Sara became Consultant Microbiologist at Ashford Public Health Laboratory in 1999 and subsequently moved to Kent Health Protection Unit as Consultant in Communicable Disease Control in 2004. Whilst at Kent HPU she advised MTW on the investigation and management of the outbreak of C. difficile in 2005/6 which was the subject of a highly critical Healthcare Commission report in October 2007. In November 2007, Sara took up the post of DIPC at MTW and has led the improvements which have seen a 96% reduction (compared with 2005/6) in C. difficile cases to 7.4/100 000 bed days, earning recognition from the Trust Development Authority (now NHSI) as an exemplar site for infection prevention.

Lisa White

Assistant Director of Infection Prevention and Control at Kent Community Health NHS Foundation Trust.

Lisa Trained at Guys and ST.Thomas NHS Foundation Trust and qualified in 1993, where she undertook a variety of roles. In 2005 Lisa joined the Infection Prevention and Control team at the Trust, where she was part of the team that helped reduce the HCAI’s at GSTT significantly over the next 5 years.


Lisa’s focus changed to the community setting in 2010, when she became the Lead Infection Prevention and Control Advisor for Lambeth and Southwark PCT, and supported them through a CQC assessment, and restructure. In 2012 she moved to Kent Community Health NHS Foundation Trust, where she has helped the organisation to focus on the wider community aspects of Infection Prevention and Control. Lisa continues to work closely with colleagues in Kent to ensure health economy wide changes are implemented effectively to improve patient safety.

Celia Ingham Clark is the Medical Director for Clinical Effectiveness at NHS England.


She trained in Cambridge and London and was appointed as a consultant general surgeon at the Whittington Hospital in 1996.


 After early work in medical education she developed an interest in quality improvement and this took her through several medical management roles to become Medical Director of the trust from 2004-2012.


More recently she worked as national clinical director for acute surgery and enhanced recovery, and as London regional lead for revalidation and quality.


For two years from 2014 she was the NHS England Director for reducing premature mortality, and in 2016 became the Medical Director for Clinical Effectiveness.

She was awarded an MBE in 2013 for services to the NHS.

Celia Ingham Clark MBE 

National Director for Reducing Premature Deaths, NHS England

Elizabeth Beech

Pharmacist at NHS Bath and North East Somerset CCG and National Project Lead HAI & AMR NHS Improvement

Elizabeth Beech currently works as one of three national project leads for Healthcare Acquired Infections and Antimicrobial Resistance within the Patient Safety Domain at NHS Improvement - supporting the implementation of the UK Antimicrobial Resistance Strategy. Elizabeth studied pharmacy at Aston University in Birmingham and moved to work within hospitals in the London region, including teaching at London University and researching pharmacy practice. Three children and very many jobs later, Elizabeth continues to work within the NHS as a commissioning pharmacist in NHS Bath and North East Somerset CCG, has joined the  community and tweets @elizbeech

Stuart Brown

National Project Leads HAI & AMR NHS Improvement

Stuart Brown currently works as an antimicrobial pharmacist at County Durham and Darlington NHS Foundation Trust and has spent the last 10 years working within secondary care.

He is a keen advocate of antimicrobial stewardship, presenting on this at both local and national conferences.

Stuart works closely with his colleagues in primary care and is the current chair of the Antimicrobial Pharmacist Group in the North East of England. He is currently seconded to NHS Improvement as a national project lead for AMR and HCAI’s.

Linda Dempster

Head of Infection Prevention and Control at NHS Improvement

Linda held the post of Deputy Director IPC at The Medway NHS Foundation Trust between 2016 and 2014. She then progressed to The NHS Trust Development Authority as Head Of IPC (South of England), before becoming the National Lead for IPC for NHS Improvement in 2017.